Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.125B-$1.195B
Benzinga Newsdesk 8 months ago
NewsGuidance
Indivior Pharmaceuticals (NASDAQ:INDV) affirms FY2026 sales outlook from $1.125 billion-$1.195 billion to $1.125 billion-$1.195 billion.
Indivior Pharmaceuticals (NASDAQ:INDV) affirms FY2026 sales outlook from $1.125 billion-$1.195 billion to $1.125 billion-$1.195 billion.